Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Heidi, Wat"'
Publikováno v:
Lasers in Surgery and Medicine. 53:9-49
Background and objectives The use of picosecond laser in dermatology was originally focused on optimizing the removal of unwanted tattoos. Subsequent advances in this technology have broadened its clinical indications to include treatment of benign p
Publikováno v:
Journal of the American Academy of Dermatology. 87(2)
Publikováno v:
Lasers in Surgery and Medicine. 51:8-13
BACKGROUND AND OBJECTIVES The picosecond alexandrite laser with diffractive lens array (DLA) offers the dual advantages of a picosecond pulse duration and the fractionated delivery of laser energy. This study explores the efficacy and safety of the D
Publikováno v:
Dermatologic Clinics. 36:49-55
Noninvasive body contouring is an attractive therapeutic modality to enhance the ideal male physique. Men place higher value on enhancing a well-defined, strong, masculine jawline and developing a V-shaped taper through the upper body. An understandi
Publikováno v:
Journal of the American Academy of Dermatology. 83(2)
Publikováno v:
Lasers in Surgery and Medicine. 49:45-59
Background and Objective Fractionated photothermolysis (FP) has revolutionized modern laser technology. By creating selective columns of microthermal damage, fractionated devices allows for greater treatment depths to be achieved without the prolonge
Publikováno v:
Lasers in surgery and medicine. 51(1)
The picosecond alexandrite laser with diffractive lens array (DLA) offers the dual advantages of a picosecond pulse duration and the fractionated delivery of laser energy. This study explores the efficacy and safety of the DLA for treatment of multip
Publikováno v:
Dermatologic clinics. 36(1)
Noninvasive body contouring is an attractive therapeutic modality to enhance the ideal male physique. Men place higher value on enhancing a well-defined, strong, masculine jawline and developing a V-shaped taper through the upper body. An understandi
Publikováno v:
Dermatologic Surgery. 40:359-377
The Food and Drug Administration (FDA) has approved intense pulsed light (IPL) devices for the treatment of a variety of benign pigmentary and vascular lesions, but the range of disease amenable to IPL treatment continues to expand, and there are no
Autor:
Heidi Wat, Thomas G. Salopek
Publikováno v:
Journal of the American Academy of Dermatology. 76(1)